Month: April 2024

MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that the Company will present two late-breaking abstract presentations at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting, taking place May 9-11, 2024 in New Orleans, LA. The late-breaking presentations are: Double-Blind, Multiple Ascending Dose, Safety, Pharmacokinetic and Body Composition Study of Enobosarm in Healthy Young and Older MenDate: Thursday May 9, 2024Start and end time: 12:25 PM-12:40 PM Central Daylight Time Potential to Optimize Weight Loss with Enobosarm: Augment Reduction of Fat Mass while Preserving...

FAIRFIELD, N.J., April 25, 2024 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter ended March 31, 2024 of $7.4 million, or $0.12 per diluted share, compared to a net loss of $13.8 million, or $0.22 per diluted share, for the quarter ended December 31, 2023. The net loss for the quarter ended December 31, 2023 was impacted by various non-recurring items, as previously disclosed. The Company also announced that its Board of Directors has declared a quarterly cash dividend of $0.11 per share, payable on May 22, 2024, to stockholders of record as of May 8, 2024. Craig L. Montanaro, President and Chief Executive Officer, commented, “Once again uncertainty remains on the forefront of conversations taking place on Main Street...

ISLAND PARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) — NetBrands Corp., a Delaware corporation (the “Company”; OTC: NBND) is pleased to announce that the company has filed an application to uplist to the OTCQB Venture Market and move to the higher-tier of the exchange as its preparing for future moves. Company believes uplisting to the higher-tier of OTC will provide an opportunity for a more efficient access to U.S Investors, greater transparency, enhanced liquidity and potentially achieving higher valuation. Our recent announcement of Intent to acquire OMM Imports, LLC, Elevare Skincare, LLC and Market Innovations, LLC (“Zero Gravity”) signifies our commitment to deliver shareholder value and give access and larger exposure with reach to a greater investor base on OTCQB Venture Market. “As the company going through a pivotal point,...

BOULDER, Colo., April 25, 2024 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, announced that the second season of its highly-anticipated original series The Journey of Remembering is now available exclusively on Gaia. The premiere of this eight-episode series includes the first three episodes, with new episodes released each Monday at 2:00 a.m. MT. In season two of this exclusive Gaia Original docuseries, Matías De Stefano guides 45 initiates on a challenging journey he took himself years ago. Together, the group travels to stone circles and sacred sites throughout Great Britain, retracing an ancient path of initiation. Along the way, they practice Druidic ceremonies led by wise “Merlins,” learning how to work with powerful Earth energies and heal buried memories and emotions that have been...

Brokerage Ranked Number Two for The Highest Agent Count and Number Three in Real Estate Sales in Polk County, Florida in 2023 Reaffirms target anticipated to generate $100 million of annualized revenue as a 2024 exit run rate Celebration, FL, April 25, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for five agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced that it has completed an acquisition transaction and now holds a 51% interest in the Company’s franchisee – La Rosa Realty Lakeland LLC (DBA La Rosa Realty Prestige) (“Prestige”), located in Lakeland, Florida with a separate branch in Winter Haven, Florida. Prestige generated revenue of $4.7 million and had positive net income in 2023. The franchisee provides...

FREMONT, Calif., April 25, 2024 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI) (formerly ShotSpotter, Inc.), a leading public safety technology company, will hold a conference call on Tuesday, May 14, 2024 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call. SoundThinking management will host the presentation, followed by a question-and-answer period. Date: Tuesday, May 14, 2024Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)U.S. dial-in: 877-407-8029International dial-in: 1-201-689-8029Conference ID: 13746236 A live audio webcast of the conference call will be available in listen-only mode simultaneously and available for replay here and via the investor relations section...

WOBURN, Mass., April 25, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing technology software, announced today that a leading office-supply manufacturer has implemented HawkSearch on its eCommerce site. The manufacturer will use HawkSearch AI to increase online revenue for over 500,000 product searches per month. HawkSearch AI will increase conversions through features such as autocomplete. A shopper can begin to type “student” and autocomplete will use past search behavior to predict that the intended query is “student desks” and displays popular matches before the shopper even finishes typing. This leads to faster conversion for each search query. HawkSearch Recommendations powers a personalized shopping experience to increase the average order size. For instance, when a shopper searches...

ST. GALLEN, Switzerland, April 25, 2024 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD) (“Sportradar”) will release its financial and operating results for the first quarter ended March 31, 2024 on Wednesday, May 15, 2024. Sportradar will also host an earnings call via webcast to discuss the results at 8:30 a.m. ET on Wednesday, May 15, 2024. Those wishing to either listen to, or participate in, the earnings webcast can do so by accessing Sportradar’s Investor Relations website at https://investors.sportradar.com. Additionally, a replay will be posted on the Investor Relations website for one year after the conclusion of the event. About SportradarSportradar Group AG (NASDAQ: SRAD), founded in 2001, is a leading global sports technology company creating immersive experiences for sports fans and bettors. Positioned at the...

TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close. The Company will host a conference call to discuss the results the following morning, May 15th, at 8:30 a.m. ET. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate via phone, listeners calling from the U.S. and Canada may dial 800-715-9871 using the conference ID 4304270. A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page. About Prestige Consumer...

BOSTON, April 25, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that it will be sharing new preliminary data from the ongoing AMPLIFY-7P Phase 1/2 study in a poster presentation at the 2024 American Society of Clinical Oncology (“ASCO”) Annual Meeting, being held May 31-June 4, 2024 in Chicago, IL. The AMPLIFY-7P study is evaluating the 7-peptide formulation of Elicio’s off-the-shelf investigational therapeutic cancer vaccine candidate, ELI-002 7P, in patients with mKRAS-driven solid tumors that are positive for minimal residual disease. ELI-002 7P is designed to stimulate an immune response against the seven KRAS mutations that drive 25% of all...